Circulating tumor cells as biomarkers in lung cancer 

Presence of tumor associated macrophages in SHH medulloblastoma 

Steatosis induces Wnt/β-catenin pathway to stimulate proliferation of hepatic tumor initiating cells and promote liver cancer development 

The selective targeting of Ras: a tale of kinetics, mRNA display, and vaccines 

A mutant recombinant immunotoxin αFAP-PE38 for melanoma treatment in mice 

Utilizing neurodevelopment to discover molecular pathways promoting medulloblastoma metastasis 

Detection of mitochondrial DNA variants at low level heteroplasmy in pediatric CNS and extra-CNS solid tumors with three different enrichment methods 

Exploration of the roles of cancer stem cells and survivin in the pathogenesis and progression of prostate cancer 

Evaluating the impact of long non-coding RNAs on tumor mutational burden in cancer 

Exploring the effects of CXCR4 inhibition on circulating tumor cell populations in metastatic prostate cancer 

Systems pharmacology for acute myeloid leukemia and feedback control pharmacodynamic models 

Targeting vessel maturation: an anti-angiogenesis based cancer therapy 

Modulation of human tumor antigen-specific T cell responses by programmed death-1 blockade 

Stochastic multidrug adaptive chemotherapy control of competitive release in tumors 

Let there be LIGHT: TNFSF14 immunomodulating properties for cancer immunotherapy 

A phase I study of vincristine, escalating doses of irinotecan, temozolomide and bevacizumab (VIT-B) in pediatric and adolescent patients with recurrent or refractory solid tumors of non-hematopo... 

The effect of tumor-mediated immune suppression on prostate cancer immunotherapy 

Genetic and environmental risk factors for childhood cancer 

Site-specific PEGylation of recombinant immunotoxin antiFAP-CD8h-PE38 with an expanded genetic code 

Development of a colorectal cancer-on-chip to investigate the tumor microenvironment's role in cancer progression 

pRB structures and functions mediating suppression of retinoblastoma initiation 

Stable expression of human B7-H4 in a mouse mammary tumor model as a target for cancer immunotherapy 

Combination therapy for solid tumor 

Establishing the non-coding RNA LINC00261 as a tumor suppressor in lung adenocarcinoma 

Establishing a human EGFR expressing murine mammary carcinoma cell line-D2F2, as a syngeneic immunocompetent model